Eton Pharmaceuticals, Inc. Investing Cash Flow
Eton Pharmaceuticals, Inc. (ETON) reported Investing Cash Flow of -$15.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $5.00K.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$15.07M.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$49.00K.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$284.00K.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$333.00K.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$40.01M.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$775.00K.
- Eton Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$2.79M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 8 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$15.07M 10-Q · filed 2026-08-13 | -$15.12M derived: sum of 3 quarters · filed 2026-08-13 | -$15.40M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$15.07M 10-Q · filed 2026-05-14 | -$15.12M derived: sum of 2 quarters · filed 2026-05-14 | -$15.41M derived: sum of 3 quarters · filed 2026-05-14 | -$15.41M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$333.00K derived: sum of 2 quarters · filed 2026-03-19 | -$333.00K derived: sum of 3 quarters · filed 2026-08-13 | -$333.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | -$284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$284.00K derived: sum of 2 quarters · filed 2026-08-13 | -$284.00K 10-Q · filed 2025-11-06 | -$38.42M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | -$38.13M derived: sum of 3 quarters · filed 2026-08-13 | -$38.13M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$38.13M derived: sum of 2 quarters · filed 2026-05-14 | -$38.13M derived: sum of 3 quarters · filed 2026-05-14 | -$38.13M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$38.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$38.13M derived: sum of 2 quarters · filed 2026-03-19 | -$38.13M derived: sum of 3 quarters · filed 2026-03-19 | -$40.01M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | -$1.88M 10-Q · filed 2025-11-06 | -$2.66M derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.88M 10-Q · filed 2025-08-07 | -$2.66M derived: sum of 3 quarters · filed 2026-03-19 | -$2.66M derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-03-31 | -$1.88M 10-Q · filed 2025-05-13 | -$2.66M derived: sum of 2 quarters · filed 2026-03-19 | -$2.66M derived: sum of 3 quarters · filed 2026-03-19 | -$2.66M derived: sum of 4 quarters · filed 2026-03-19 | |
| 2023-12-31 | -$775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$775.00K derived: sum of 2 quarters · filed 2026-03-19 | -$775.00K derived: sum of 3 quarters · filed 2026-03-19 | -$775.00K 10-K · filed 2026-03-19 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$12.00K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$12.00K derived: sum of 3 quarters · filed 2025-03-18 | -$2.01M derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | -$12.00K derived: sum of 2 quarters · filed 2025-03-18 | -$2.01M derived: sum of 3 quarters · filed 2025-03-18 | -$2.77M derived: sum of 4 quarters · filed 2025-03-18 | |
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.01M derived: sum of 2 quarters · filed 2025-03-18 | -$2.77M derived: sum of 3 quarters · filed 2025-03-18 | -$2.79M 10-K · filed 2025-03-18 | |
| 2022-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.76M derived: sum of 2 quarters · filed 2023-11-09 | -$2.78M 10-Q · filed 2023-11-09 | -$6.03M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | -$761.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$776.00K 10-Q · filed 2023-08-10 | -$4.03M derived: sum of 3 quarters · filed 2024-03-14 | -$4.03M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | -$15.00K 10-Q · filed 2023-05-11 | -$3.27M derived: sum of 2 quarters · filed 2024-03-14 | -$3.27M derived: sum of 3 quarters · filed 2024-03-14 | ||
| 2021-12-31 | -$3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$3.26M derived: sum of 2 quarters · filed 2024-03-14 | -$2.56M 10-K · filed 2024-03-14 | ||
| 2021-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $695.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $697.00K 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$46.00K derived: sum of 2 quarters · filed 2023-03-16 | -$46.00K derived: sum of 3 quarters · filed 2023-03-16 | -$50.00K 10-K · filed 2023-03-16 | |
| 2020-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-16 | -$2.00K derived: sum of 2 quarters · filed 2021-11-16 | -$6.00K 10-Q · filed 2021-11-16 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$4.00K 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | -$4.00K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$1.85M 10-K · filed 2022-03-16 | ||||
| 2018-12-31 | -$236.00K 10-K · filed 2021-03-16 | ||||
| 2017-12-31 | -$130.00K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |